ARA-290 — 2 mg

ARA-290 — 2 mg

ARA-290 is a synthetic peptide derived from erythropoietin (EPO), widely studied in research settings for its selective interaction with tissue-protective and inflammatory signaling pathways. Researchers examine it for how it influences cellular protection mechanisms, immune modulation, and downstream repair-associated markers without activating erythropoiesis or other hematologic effects linked to full-length EPO.

Key Research Observations on ARA-290

Selective activation of tissue-protective pathways
Research literature describes ARA-290 as an EPO-derived peptide that engages the innate repair receptor (IRR), a signaling complex associated with cellular protection and regeneration rather than red blood cell production.

Lack of erythropoietic activity
Studies note that ARA-290 does not stimulate hematocrit or hemoglobin production, distinguishing it from native erythropoietin and making it suitable for non-hematologic research models.

Investigation into inflammatory signaling modulation
Preclinical research explores how ARA-290 may influence inflammatory cytokine signaling and immune response regulation in models of tissue stress and injury.

Interest in cellular repair and neuroprotective research
Academic and experimental studies examine ARA-290 for its downstream effects on tissue resilience, nerve signaling pathways, and cellular recovery markers under controlled research conditions.